← 홈

대장·직결장암

255개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-14 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 255개
ADCBiologicGruppo Oncologico del Nord-OvestPhase 3

l-leucovorin (l-leucovorin)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 36.6%임상시험 60상태 ACTIVE
CGTBiologicSPP Pharmaclon Ltd.Phase 2

Recombinant Interferon Alfa (Recombinant Interferon Alfa)

Colorectal Cancer; Kidney Cancer · Bladder Cancer

#BladderCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 32.4%임상시험 59상태 ACTIVE
ADCBiologicPfizerderuxtecan and tucatinibPhase 3

Tucatinib (Tucatinib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
CGTBiologicNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 ACTIVE
ADCBiologicDaiichi Sankyoderuxtecan (T-DXd) in FISH-…Phase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, DS-8201a)

Colorectal Neoplasm · Malignant Neoplasm of Breast

#MalignantNeoplasmofBreast#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 74.1%임상시험 53상태 DISCONTINUED
AntibodyJanssenderuxtecan, datopotamab der…Phase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#인기#항체+5
효능 ORR 4.3%임상시험 51상태 RECRUITING
ADCBiologicAmgenbiodistributionPhase 2

Sotorasib (Sotorasib)

Colorectal Cancer; Resectable Colorectal Carcinoma · Locally Advanced Lung Non-Small Cell Car

#LocallyAdvancedLungNon-SmallCell#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 51상태 RECRUITING
AntibodyGruppo Oncologico del Nord-OvestPhase 2

Balstilimab (Balstilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 45상태 RECRUITING
CGTBiologicViroMissile, Inc.foreignPhase 1

oncolytic vaccinia virus (IDOV-Immune, IDOV-Immune (oncolytic vaccinia virus))

Colorectal Cancer; Pancreatic Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 80%임상시험 40상태 RECRUITING
ADCBiologicMirati Therapeutics Inc.biodistributionPhase 3

Adagrasib (Adagrasib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 31.9%임상시험 38상태 RECRUITING
AntibodyGruppo Oncologico del Nord-OvestPhase 2

Botensilimab (Botensilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 38상태 RECRUITING
CGTBiologicAbbVievedotin (RC48) with the est…Phase 2

Granulocyte Colony-Stimulating Factor (Granulocyte Colony-Stimulating Factor)

AML, Childhood; Aml · AML, Childhood

#AMLChildhood#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 20.4%임상시험 32상태 RECRUITING
AntibodyEli LillyPhase 2

Cetuximab + mFOLFOX6 (Cetuximab + mFOLFOX6)

Neoadjuvant Treatment; Rectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+4
효능 ORR 55%임상시험 31상태 RECRUITING
AntibodystaleGilead SciencesPhase 2

Magrolimab (Magrolimab)

Solid Tumor; Colorectal Cancer · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+4
효능 ORR 66.7%임상시험 30상태 DISCONTINUED
ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 69.3%임상시험 30상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 50%임상시험 30상태 ACTIVE
AntibodystaleRochePhase 2

CapeOX + bevacizumab (CapeOX + bevacizumab)

Unresectable Metastatic Colorectal Cancer; Microsatellite Stable (MSS) Colorectal Cancer (CRC) · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+4
임상시험 25상태 RECRUITING
AntibodystalePfizerPhase 1

sasanlimab (sasanlimab)

Carcinoma, Pancreatic Ductal; Colorectal Neoplasms · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase1#항체#면역항체+5
효능 ORR 33.3%임상시험 23상태 DISCONTINUED
ADCBiologicstaleHansoh BioMedical R&D CompanyPhase 2

HS-20093 (HS-20093)

Advanced Solid Tumor · Metastatic Colorectal Cancer (CRC)

#MetastaticColorectalCancerCRC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 22상태 RECRUITING
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CEA-targeted CAR-T cells (CEA-targeted CAR-T cells)

Gastric Cancer; Colon Cancer · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 19상태 ACTIVE

2 / 13 페이지

← 이전다음 →